CEMIPLIMAB-RWLC vs IPILIMUMAB

Compare CEMIPLIMAB-RWLC (LIBTAYO) and IPILIMUMAB (YERVOY) — clinical data, side effects, and patient experiences.

CEMIPLIMAB-RWLC

LIBTAYO · Immune Checkpoint Inhibitor

How it works

12.1 Mechanism of Action Binding of the PD-1 ligands PD-L1 and PD-L2 to the PD-1 receptor found on T cells inhibits T-cell proliferation and cytokine production. Upregulation of PD...

Approved for

with no EGFR

ALK or ROS1 aberrations

and is: locally advanced where patients are not candidates for surgical resection or definitive chemoradiation or metastatic. ( 1.3

with no EGFR

IntravenousTablet

IPILIMUMAB

YERVOY, Yervoy · Immune Checkpoint Inhibitor

How it works

12.1 Mechanism of Action CTLA-4 is a negative regulator of T-cell activity. Ipilimumab is a monoclonal antibody that binds to CTLA-4 and blocks the interaction of CTLA-4 with its l...

Approved for

including total lymphadenectomy. (1.2) Renal Cell Carcinoma (RCC) • Treatment of adult patients with intermediate or poor risk advanced renal cell carcinoma

with no EGFR or ALK genomic tumor aberrations

in combination with nivolumab and 2 cycles of platinum-doublet chemotherapy. (1.6) Malignant Pleural Mesothelioma • Treatment of adult patients with unresectable malignant pleural mesothelioma

as first-line treatment in combination with nivolumab. (1.7) Esophageal Cancer • Treatment of adult patients with unresectable advanced or metastatic esophageal squamous cell carcinoma

IntravenousTablet

Quick Comparison

CEMIPLIMAB-RWLCIPILIMUMAB

Drug Class

Immune Checkpoint Inhibitor

Route

Intravenous

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

CEMIPLIMAB-RWLC

Fatigue

1-10%

Rash

1-10%

Shortness of Breath

1-10%

Fever

1-10%

Itching

0.1-1%

Weakness

0.1-1%

Diarrhea

0.1-1%

Nausea

0.1-1%

IPILIMUMAB

Diarrhea

>10%

Fever

1-10%

Rash

1-10%

Fatigue

1-10%

Nausea

0.1-1%

Decreased Appetite

0.1-1%

Vomiting

0.1-1%

Shortness of Breath

0.1-1%

FDA Warnings

CEMIPLIMAB-RWLC

5 WARNINGS AND PRECAUTIONS Immune-Mediated Adverse Reactions ( 5
1 ) Immune-mediated adverse reactions, which may be severe or fatal, can occur in any organ system or tissue, including the following: immune-mediated pneumonitis, immune-mediated colitis, immune-mediated hepatitis, immune-mediated endocrinopathies, immune-mediated dermatologic adverse reactions, immune-mediated nephritis and renal dysfunction, and solid organ transplant rejection
2 ) Complications of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Fatal and other serious complications can occur in patients who receive allogeneic HSCT before or after being treated with a PD-1/PD-L1 blocking antibody
Advise females of reproductive potential of the potential risk to a fetus and use of effective contraception

IPILIMUMAB

5 WARNINGS AND PRECAUTIONS • Severe and Fatal Immune-Mediated Adverse Reactions : Immune-mediated adverse reactions (IMAR) can occur in any organ system or tissue, including the following: immune-mediated colitis, immune-mediated hepatitis, immune-mediated dermatologic adverse reactions, immune-mediated endocrinopathies, immune-mediated pneumonitis, and immune-mediated nephritis with renal dysfunction, and can occur at any time during treatment or after discontinuation
2 ) • Complications of allogeneic HSCT : Fatal and other serious complications can occur in patients who receive allogeneic HSCT before or after being treated with YERVOY
Advise of potential risk to a fetus and use of effective contraception
1 Severe and Fatal Immune-Mediated Adverse Reactions YERVOY is a fully human monoclonal antibody that blocks T-cell inhibitory signals induced by the CTLA-4 pathway, thereby removing inhibition of the immune response with the potential for induction of immune-mediated adverse reactions

Community Sentiment Analysis

Based on 10 Reddit discussions

CEMIPLIMAB-RWLC

positive

1 threads

IPILIMUMAB

44%

positive

9 threads

Community-Reported Side Effects

% of discussions mentioning each side effect

Community Discussions

1 Reddit threads analysed for CEMIPLIMAB-RWLC

Overall Sentiment

Mixed

Comparison Threads

Avg Post Score

20 upvotes

Most discussed side effects in community

Muscle Pain (1)

Sexual Dysfunction (1)

Patient Experiences (r/pharmacy, r/AskDocs & more)

Your Morning Coffee: 10/09/2018

# EARNINGS Helen of Troy (HELE) Q2 Adj. EPS USD 1.98 vs. Exp. USD 1.60, revenue USD 393.55mln vs. Exp. USD 349.19mln; raises FY19 Adj. EPS USD 7.65-7.90 vs. Exp. USD 7.62. (Newswires) #DJIA Apple (AAPL) – The behemoth’s 2018 iPad Pro models are to include edge-to-edge displays, Face ID, USB

r/wallstreetbets2017y ago

Muscle Pain

Sexual Dysfunction

Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.

Community Discussions

9 Reddit threads analysed for IPILIMUMAB

Overall Sentiment

Mixed

Comparison Threads

Avg Post Score

54 upvotes

Most discussed side effects in community

Fatigue (2)

Cough (2)

Headache (1)

Anxiety (1)

Sexual Dysfunction (1)

Brain Fog (1)

Patient Experiences (r/pharmacy, r/AskDocs & more)

Clinical Trials by Country - Excluding USA

Last Updated: May 11, 2025 In order to advance research and acquire treatments, it is necessary we participate in clinical trials whenever possible. The faster these trials are completed, the faster we can get treatments. If you are able, please consider looking through this guide to find a trial th

r/covidlonghaulers128481y ago

Headache

Fatigue

Anxiety

2.5yrs post stage IV melanoma - AMA

Hello everyone: I am writing this post, I guess, because I wanted to share my experience with anyone who might have questions about melanoma from someone who’s been through almost everything modern treatment can throw at me. I’ve also done some peer support volunteering, and have experienced firstha

r/cancer77595y ago

Nothing New Here

With the commitment of the [$30 million funding from Yorkville Advisors Global](https://www.cytodyn.com/newsroom/detail/649/cytodyn-secures-30-million-commitment-from-yorkville), CytoDyn continues to pursue its goals and ambitions, not just in ColoRectal Cancer, but in all its endeavors. Who signed

r/Livimmune52346mo ago

Weight Loss

Vision Changes

Oncotelic Therapeutics, Inc Recap (OTCQB: $OTLC)

Oncotelic is an immuno-oncology company based out of California, with over 30 years of experience in their management team, they have dedicated themselves to developing the first in class RNA therapeutics as well as small molecule drugs against cancer and infectious diseases. A they have filed over

r/smallcaps4903y ago

Stage IV Sudden shock diagnosis after kidney stones, no primary.

Hellllloooo From (thankfully not sunny) London 🌧️ So… I moved to London on 12th Jan for a fresh start New chapter. Big city energy. Maybe a bit of culture. Maybe a coffee that costs more than my first car. Juggling which job offer to take and which house to choose to get us out of the Airbnb. Inst

r/Melanoma47332mo ago

Rash

Longform: My Cancer Journey

I've been posting here for a bit, so I thought I should share my story as well. I hope it helps someone in their journey. It's a super long one, because I love writing stories, and it's super easy when it was factual and I was present for all of it. If you want a TD;LR version, I had colon cancer. I

r/coloncancer45101y ago

Fatigue

Stomach Pain

Edema

Martin Shkreli Blog - 18/11/17

11/17/2018 - Copy of blog found at martinshkreli.com Biopharma/Investing ————————— Celgene deep-dive is progressing smoothly. I’ve skimmed hundreds of papers (4000 Revlimid entries in Pubmed), docket entries and more in preparation. Thanks for the crazy amount of mail. Fascinating, if not desperate,

r/wallstreetbets4457y ago

Oncotelic Therapeutics, Inc (OTCQB: $OTLC)

Financials, Market Cap: 38.999M USD Current Price: 0.1100 USD 52 Week Range: 0.0800 - 0.2600 USD Average Volume: 228,763 (As of July 14th, 2022) &#x200B; [https://ca.finance.yahoo.com/quote/OTLC?p=OTLC&.tsrc=fin-srch](https://ca.finance.yahoo.com/quote/OTLC?p=OTLC&.tsrc=fin-srch) &#x

r/biotech_stocks2923y ago

Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.

CEMIPLIMAB-RWLC vs IPILIMUMAB: What You Should Know

Key Differences

Both CEMIPLIMAB-RWLC and IPILIMUMAB belong to the Immune Checkpoint Inhibitor class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

CEMIPLIMAB-RWLC carries 4 FDA warnings. IPILIMUMAB carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

CEMIPLIMAB-RWLC vs PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH→CEMIPLIMAB-RWLC vs DOSTARLIMAB→AVELUMAB vs CEMIPLIMAB-RWLC→CEMIPLIMAB-RWLC vs Nivolumab→IPILIMUMAB vs Nivolumab→IPILIMUMAB vs PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH→

Loading comparison data...

CEMIPLIMAB-RWLC vs IPILIMUMAB

Compare CEMIPLIMAB-RWLC (LIBTAYO) and IPILIMUMAB (YERVOY) — clinical data, side effects, and patient experiences.

CEMIPLIMAB-RWLC

LIBTAYO · Immune Checkpoint Inhibitor

How it works

12.1 Mechanism of Action Binding of the PD-1 ligands PD-L1 and PD-L2 to the PD-1 receptor found on T cells inhibits T-cell proliferation and cytokine production. Upregulation of PD...

Approved for

with no EGFR

ALK or ROS1 aberrations

and is: locally advanced where patients are not candidates for surgical resection or definitive chemoradiation or metastatic. ( 1.3

with no EGFR

IntravenousTablet

IPILIMUMAB

YERVOY, Yervoy · Immune Checkpoint Inhibitor

How it works

12.1 Mechanism of Action CTLA-4 is a negative regulator of T-cell activity. Ipilimumab is a monoclonal antibody that binds to CTLA-4 and blocks the interaction of CTLA-4 with its l...

Approved for

including total lymphadenectomy. (1.2) Renal Cell Carcinoma (RCC) • Treatment of adult patients with intermediate or poor risk advanced renal cell carcinoma

with no EGFR or ALK genomic tumor aberrations

in combination with nivolumab and 2 cycles of platinum-doublet chemotherapy. (1.6) Malignant Pleural Mesothelioma • Treatment of adult patients with unresectable malignant pleural mesothelioma

as first-line treatment in combination with nivolumab. (1.7) Esophageal Cancer • Treatment of adult patients with unresectable advanced or metastatic esophageal squamous cell carcinoma

IntravenousTablet

Quick Comparison

CEMIPLIMAB-RWLCIPILIMUMAB

Drug Class

Immune Checkpoint Inhibitor

Route

Intravenous

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

CEMIPLIMAB-RWLC

Fatigue

1-10%

Rash

1-10%

Shortness of Breath

1-10%

Fever

1-10%

Itching

0.1-1%

Weakness

0.1-1%

Diarrhea

0.1-1%

Nausea

0.1-1%

IPILIMUMAB

Diarrhea

>10%

Fever

1-10%

Rash

1-10%

Fatigue

1-10%

Nausea

0.1-1%

Decreased Appetite

0.1-1%

Vomiting

0.1-1%

Shortness of Breath

0.1-1%

FDA Warnings

CEMIPLIMAB-RWLC

5 WARNINGS AND PRECAUTIONS Immune-Mediated Adverse Reactions ( 5
1 ) Immune-mediated adverse reactions, which may be severe or fatal, can occur in any organ system or tissue, including the following: immune-mediated pneumonitis, immune-mediated colitis, immune-mediated hepatitis, immune-mediated endocrinopathies, immune-mediated dermatologic adverse reactions, immune-mediated nephritis and renal dysfunction, and solid organ transplant rejection
2 ) Complications of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Fatal and other serious complications can occur in patients who receive allogeneic HSCT before or after being treated with a PD-1/PD-L1 blocking antibody
Advise females of reproductive potential of the potential risk to a fetus and use of effective contraception

IPILIMUMAB

5 WARNINGS AND PRECAUTIONS • Severe and Fatal Immune-Mediated Adverse Reactions : Immune-mediated adverse reactions (IMAR) can occur in any organ system or tissue, including the following: immune-mediated colitis, immune-mediated hepatitis, immune-mediated dermatologic adverse reactions, immune-mediated endocrinopathies, immune-mediated pneumonitis, and immune-mediated nephritis with renal dysfunction, and can occur at any time during treatment or after discontinuation
2 ) • Complications of allogeneic HSCT : Fatal and other serious complications can occur in patients who receive allogeneic HSCT before or after being treated with YERVOY
Advise of potential risk to a fetus and use of effective contraception
1 Severe and Fatal Immune-Mediated Adverse Reactions YERVOY is a fully human monoclonal antibody that blocks T-cell inhibitory signals induced by the CTLA-4 pathway, thereby removing inhibition of the immune response with the potential for induction of immune-mediated adverse reactions

Community Sentiment Analysis

Based on 10 Reddit discussions

CEMIPLIMAB-RWLC

positive

1 threads

IPILIMUMAB

44%

positive

9 threads

Community-Reported Side Effects

% of discussions mentioning each side effect

Community Discussions

1 Reddit threads analysed for CEMIPLIMAB-RWLC

Overall Sentiment

Mixed

Comparison Threads

Avg Post Score

20 upvotes

Most discussed side effects in community

Muscle Pain (1)

Sexual Dysfunction (1)

Patient Experiences (r/pharmacy, r/AskDocs & more)

Your Morning Coffee: 10/09/2018

r/wallstreetbets2017y ago

Muscle Pain

Sexual Dysfunction

Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.

Community Discussions

9 Reddit threads analysed for IPILIMUMAB

Overall Sentiment

Mixed

Comparison Threads

Avg Post Score

54 upvotes

Most discussed side effects in community

Fatigue (2)

Cough (2)

Headache (1)

Anxiety (1)

Sexual Dysfunction (1)

Brain Fog (1)

Patient Experiences (r/pharmacy, r/AskDocs & more)

Clinical Trials by Country - Excluding USA

r/covidlonghaulers128481y ago

Headache

Fatigue

Anxiety

2.5yrs post stage IV melanoma - AMA

r/cancer77595y ago

Nothing New Here

r/Livimmune52346mo ago

Weight Loss

Vision Changes

Oncotelic Therapeutics, Inc Recap (OTCQB: $OTLC)

r/smallcaps4903y ago

Stage IV Sudden shock diagnosis after kidney stones, no primary.

r/Melanoma47332mo ago

Rash

Longform: My Cancer Journey

r/coloncancer45101y ago

Fatigue

Stomach Pain

Edema

Martin Shkreli Blog - 18/11/17

r/wallstreetbets4457y ago

Oncotelic Therapeutics, Inc (OTCQB: $OTLC)

r/biotech_stocks2923y ago

Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.

CEMIPLIMAB-RWLC vs IPILIMUMAB: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.